HIV reservoir
Showing 1 - 25 of 8,312
HIV Infection Trial in Cleveland (Recombinant Interleukin-2)
Terminated
- HIV Infection
- Recombinant Interleukin-2
-
Cleveland, OhioAIDS Clinical Trials Unit
Sep 1, 2022
AIDS, HIV Trial in San Diego (Fluarix, Pneumovax, Placebo)
Completed
- AIDS
- HIV
- Fluarix
- +2 more
-
San Diego, CaliforniaUCSD Antiviral Research Center (AVRC)
Aug 3, 2022
HIV-1-infection Trial in Aarhus (Venetoclax)
Not yet recruiting
- HIV-1-infection
-
Aarhus, DenmarkAarhus University Hospital
Jan 5, 2023
Immune Activation and Latent HIV Reservoir Size Between People
Enrolling by invitation
- HIV-1-infection
- +3 more
- Venipuncture
- +4 more
-
Seattle, WashingtonUniversity of Washington Positive Research and the Gastroenterol
Oct 14, 2022
Reservoir in Individuals Controlling HIV Infection
Not yet recruiting
- Hiv
- (no location specified)
Aug 23, 2023
HIV Reservoir, Inflammation and Microbiota Footprint of PLWH
Recruiting
- HIV Infections
- Stool sampling
- Blood plasma collection
-
Marseille, FranceHôpital Européen Marseille
Jul 26, 2022
Analysis of the Persistence, Reservoir and HIV Latency
Not yet recruiting
- HIV Infected Individuals
- Informed Consent
- (no location specified)
Feb 28, 2023
HIV Trial (Lenalidomide, Adenosylmethionine)
Not yet recruiting
- HIV Infections
- (no location specified)
Oct 26, 2022
Role of HIV-1 Tat Protein and Anti-Tat Immune Response In HIV
Recruiting
- HIV/AIDS
- No intervention
-
Rome, ItalyInfectious Dermatology STI Unit San Gallicano Dermatologic Insti
Mar 23, 2022
HIV-1 Reservoir During Cure Interventions Studies (MERCI)
Not yet recruiting
- Hiv
-
Ghent, BelgiumGhent University Hospital
Mar 13, 2023
MEasuring the Reservoir on Cellular Level to CUre Infection
Recruiting
- Hiv
-
Ghent, BelgiumGhent University Hospital
Jan 30, 2023
HIV Trial in Barcelona (Control group , Experimental group 1 lauric acid, Experimental group 2 lauric acid)
Recruiting
- HIV Infections
- Control group placebo
- +2 more
-
Barcelona, SpainHospital Universitario Vall d´Hebron
Jan 13, 2023
Human Immunodeficiency Virus (HIV) Trial in Rochester (Ixazomib 1 MG, Ixazomib 2 MG, Ixazomib 3 MG)
Completed
- Human Immunodeficiency Virus (HIV)
- Ixazomib 1 MG
- +3 more
-
Rochester, MinnesotaMayo Clinic
Dec 8, 2021
Targeting of the Latent HIV Infected Reservoir to Cure HIV
Recruiting
- HIV Infections
- +2 more
-
Rotterdam, NetherlandsErasmus Medical Centre
Jan 17, 2022
HIV-1-infection Trial (UB-421, UB-421+chidamide)
Not yet recruiting
- HIV-1-infection
- UB-421
- UB-421+chidamide
- (no location specified)
Jul 25, 2021
HIV-1-infection Trial in Zurich (BCG Vaccine AJVaccines)
Recruiting
- HIV-1-infection
- BCG Vaccine AJVaccines
-
Zurich, SwitzerlandUniversity Hospital Zurich
Jan 28, 2022
HIV Trial in Gent (treatment interruption after in depth sampling under CART)
Completed
- HIV
- treatment interruption after in depth sampling under CART
-
Gent, Oost-Vlaanderen, BelgiumUZ Gent
Sep 29, 2021
Innovative Combinatorial stratégies of Anti-latency and
Withdrawn
- HIV
- Ex-vivo analysis
- (no location specified)
Feb 2, 2021
HIV-1-infection Trial in Los Angeles, San Francisco (PENNVAX-GP, INO-6145, INO-9012)
Completed
- HIV-1-infection
- PENNVAX-GP
- +3 more
-
Los Angeles, California
- +1 more
Apr 4, 2022
HIV-1 Infection Trial in France (Samplings)
Recruiting
- HIV-1 Infection
- Samplings
-
Clamart, France
- +6 more
Jan 4, 2022
Human Immunodeficiency Virus I Infection Trial in Seattle (Mycophenolate Mofetil 500Mg Tab)
Completed
- Human Immunodeficiency Virus I Infection
- Mycophenolate Mofetil 500Mg Tab
-
Seattle, Washington2 West Clinic at Harborview Medical Center
Nov 10, 2020
HIV-1-infection Trial in Clamart, Le Kremlin-Bicêtre, Paris (Biopsies and bloood samplings)
Not yet recruiting
- HIV-1-infection
- Biopsies and bloood samplings
-
Clamart, France
- +5 more
Jan 24, 2022
HIV, Acute HIV Infection Trial in Chapel Hill, Durham (Dolutegravir 50 mg, Lamivudine 300 mg, Abacavir 600 mg)
Completed
- HIV
- Acute HIV Infection
- Dolutegravir 50 mg
- +2 more
-
Chapel Hill, North Carolina
- +1 more
Oct 22, 2021